Literature DB >> 21629226

Synergistic inhibition of endochondral bone formation by silencing Hif1α and Runx2 in trauma-induced heterotopic ossification.

Lin Lin1, Qi Shen, Huijie Leng, Xiaoning Duan, Xin Fu, Changlong Yu.   

Abstract

Angiogenesis and osteogenesis are tightly coupled during bone development. We studied the effect of inhibition of Hif1α and Runt-related protein 2 (Runx2) on the formation of heterotopic ossification (HO). We constructed lentivirus vectors expressing Hif1α small interfering RNA (siRNA) and Runx2 siRNA. The inhibition of Hif1α function impaired osteoblast proliferation while osteoblasts differentiated normally. Osteoblasts lacking Runx2 proliferated normally while the differentiation was impaired. The osteoblast differentiation was significantly inhibited by co-Runx2 and Hif1α siRNA treatment. The formation of HO by inhibiting Runx2 and Hif1α in an animal model induced by Achilles tenotomy was investigated. The results showed that lacking of Runx2 and Hif1α could inhibit HO formation. Inhibition of Hif1α prevented HO formation only at the initial step and inhibition of Runx2 worked both at the initial step and after chondrogenesis. Angiogenesis and the expressions of osteogenic genes were downregulated in the Hif1α siRNA group. We found synergistic inhibition of endochondral bone formation by silencing Hif1α and Runx2. Our study provided new insight into the roles of Hif1α and Runx2 during the processes of endochondral bone formation, and had important implications for the new therapeutic methods to inhibit HO or to enhance bone formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21629226      PMCID: PMC3149159          DOI: 10.1038/mt.2011.101

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  33 in total

1.  Non-virus-mediated transfer of siRNAs against Runx2 and Smad4 inhibit heterotopic ossification in rats.

Authors:  T Xue; Z Mao; L Lin; Y Hou; X Wei; X Fu; J Zhang; C Yu
Journal:  Gene Ther       Date:  2009-11-26       Impact factor: 5.250

Review 2.  Role of HIF-1alpha in skeletal development.

Authors:  Chao Wan; Jin Shao; Shawn R Gilbert; Ryan C Riddle; Fanxin Long; Randall S Johnson; Ernestina Schipani; Thomas L Clemens
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

3.  Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts.

Authors:  Wen-Pei Tseng; Shu-Ning Yang; Chih-Ho Lai; Chih-Hsin Tang
Journal:  J Cell Physiol       Date:  2010-06       Impact factor: 6.384

4.  Effects of transforming growth factor-beta1 and vascular endothelial growth factor 165 gene transfer on Achilles tendon healing.

Authors:  Yu Hou; ZeBin Mao; XueLei Wei; Lin Lin; LianXu Chen; HaiJun Wang; Xin Fu; JiYing Zhang; Changlong Yu
Journal:  Matrix Biol       Date:  2009-04-21       Impact factor: 11.583

5.  HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis.

Authors:  Roy Amarilio; Sergey V Viukov; Amnon Sharir; Idit Eshkar-Oren; Randall S Johnson; Elazar Zelzer
Journal:  Development       Date:  2007-10-03       Impact factor: 6.868

6.  Hypoxia-inducible factors 1alpha and 2alpha exert both distinct and overlapping functions in long bone development.

Authors:  Stacy H Shomento; Chao Wan; Xuemei Cao; Marie-Claude Faugere; Mary L Bouxsein; Thomas L Clemens; Ryan C Riddle
Journal:  J Cell Biochem       Date:  2010-01-01       Impact factor: 4.429

7.  Heterotopic ossification induced by Achilles tenotomy via endochondral bone formation: expression of bone and cartilage related genes.

Authors:  Lin Lin; Qi Shen; Tao Xue; Changlong Yu
Journal:  Bone       Date:  2009-09-06       Impact factor: 4.398

8.  BMP type I receptor inhibition reduces heterotopic [corrected] ossification.

Authors:  Paul B Yu; Donna Y Deng; Carol S Lai; Charles C Hong; Gregory D Cuny; Mary L Bouxsein; Deborah W Hong; Patrick M McManus; Takenobu Katagiri; Chetana Sachidanandan; Nobuhiro Kamiya; Tomokazu Fukuda; Yuji Mishina; Randall T Peterson; Kenneth D Bloch
Journal:  Nat Med       Date:  2008-11-30       Impact factor: 53.440

9.  Circulating osteogenic precursor cells in heterotopic bone formation.

Authors:  Robin K Suda; Paul C Billings; Kevin P Egan; Jung-Hoon Kim; Ruth McCarrick-Walmsley; David L Glaser; David L Porter; Eileen M Shore; Robert J Pignolo
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

10.  The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.

Authors:  Ying Wang; Chao Wan; Lianfu Deng; Ximeng Liu; Xuemei Cao; Shawn R Gilbert; Mary L Bouxsein; Marie-Claude Faugere; Robert E Guldberg; Louis C Gerstenfeld; Volker H Haase; Randall S Johnson; Ernestina Schipani; Thomas L Clemens
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

View more
  24 in total

1.  Delivery of siRNA silencing Runx2 using a multifunctional polymer-lipid nanoparticle inhibits osteogenesis in a cell culture model of heterotopic ossification.

Authors:  Swati Mishra; Asa D Vaughn; David I Devore; Charles M Roth
Journal:  Integr Biol (Camb)       Date:  2012-12       Impact factor: 2.192

2.  Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification.

Authors:  Shailesh Agarwal; Shawn Loder; Cameron Brownley; David Cholok; Laura Mangiavini; John Li; Christopher Breuler; Hsiao H Sung; Shuli Li; Kavitha Ranganathan; Joshua Peterson; Ronald Tompkins; David Herndon; Wenzhong Xiao; Dolrudee Jumlongras; Bjorn R Olsen; Thomas A Davis; Yuji Mishina; Ernestina Schipani; Benjamin Levi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-31       Impact factor: 11.205

Review 3.  Heterotopic mineralization (ossification or calcification) in tendinopathy or following surgical tendon trauma.

Authors:  Etienne J O O'Brien; Cyril B Frank; Nigel G Shrive; Benedikt Hallgrímsson; David A Hart
Journal:  Int J Exp Pathol       Date:  2012-10       Impact factor: 1.925

4.  Physical and functional interactions between Runx2 and HIF-1α induce vascular endothelial growth factor gene expression.

Authors:  Tae-Geon Kwon; Xiang Zhao; Qian Yang; Yan Li; Chunxi Ge; Guisheng Zhao; Renny T Franceschi
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

5.  Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes.

Authors:  Sun-Hee Lee; Xiangguo Che; Jae-Hwan Jeong; Je-Yong Choi; Young-Joo Lee; Yong-Hee Lee; Suk-Chul Bae; You-Mie Lee
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

Review 6.  [Research progress of traumatic heterotopic ossification].

Authors:  Guorui Cao; Fuxing Pei
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-03-15

7.  Macrophage-Derived TGF-β and VEGF Promote the Progression of Trauma-Induced Heterotopic Ossification.

Authors:  Bing Tu; Juehong Li; Ziyang Sun; Tongtong Zhang; Hang Liu; Feng Yuan; Cunyi Fan
Journal:  Inflammation       Date:  2022-08-20       Impact factor: 4.657

8.  Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling.

Authors:  Haitao Wang; Carter Lindborg; Vitali Lounev; Jung-Hoon Kim; Ruth McCarrick-Walmsley; Meiqi Xu; Laura Mangiavini; Jay C Groppe; Eileen M Shore; Ernestina Schipani; Frederick S Kaplan; Robert J Pignolo
Journal:  J Bone Miner Res       Date:  2016-04-20       Impact factor: 6.741

9.  3D Hybrid Nanofiber Aerogels Combining with Nanoparticles Made of a Biocleavable and Targeting Polycation and MiR-26a for Bone Repair.

Authors:  Ruiquan Li; Hongjun Wang; Johnson V John; Haiqing Song; Matthew J Teusink; Jingwei Xie
Journal:  Adv Funct Mater       Date:  2020-09-09       Impact factor: 18.808

10.  Sox9 potentiates BMP2-induced chondrogenic differentiation and inhibits BMP2-induced osteogenic differentiation.

Authors:  Junyi Liao; Ning Hu; Nian Zhou; Liangbo Lin; Chen Zhao; Shixiong Yi; Tingxu Fan; Wei Bao; Xi Liang; Hong Chen; Wei Xu; Cheng Chen; Qiang Cheng; Yongming Zeng; Weike Si; Zhong Yang; Wei Huang
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.